Filing
1st Quarter - Report
Lobbying activity
1
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.